甲狀腺乳腺外科

　　血管、甲狀腺外科是在原普通外科的基礎(chǔ)上建立于1972年, 為國(guó)內(nèi)較早設(shè)立此?？频尼t(yī)院之一?？剖椰F(xiàn)有?？漆t(yī)師（技師）17人。其中教授4人（博士導(dǎo)師3人），副教授、副主任醫(yī)師7人，副主任技師1人，講師、主治醫(yī)師3人，住院醫(yī)師1人，技師1人。?？谱o(hù)士14人。?？茖W(xué)術(shù)水平達(dá)到國(guó)內(nèi)先進(jìn)水平，為全國(guó)重點(diǎn)學(xué)科。本學(xué)科是中華醫(yī)學(xué)會(huì)外科學(xué)會(huì)內(nèi)分泌乳腺外科學(xué)組副組長(zhǎng)，中華醫(yī)學(xué)會(huì)外科學(xué)會(huì)血管外科學(xué)組委員，中華醫(yī)學(xué)會(huì)廣東外科學(xué)會(huì)血管外科學(xué)組組長(zhǎng)和中國(guó)抗癌協(xié)會(huì)廣東乳腺癌專業(yè)委員會(huì)副主任委員的所在單位。 　　科室每年收治住院病人超過1200例，完成手術(shù)例數(shù)超過1000例。主要治療范圍有： 　　 1.胸腹主動(dòng)脈瘤、頸動(dòng)脈體瘤、 動(dòng)脈硬化閉塞癥(包括腹主動(dòng)脈、髂動(dòng)脈、頸動(dòng)脈、四肢動(dòng)脈)、急性動(dòng)脈栓塞,大動(dòng)脈炎,深靜脈瓣膜功能不全,下肢靜脈曲張,深靜脈血栓形成,布-加氏綜合癥 ，血管損傷,先天性動(dòng)靜脈瘺, 血栓閉塞性脈管炎等。 　　2.各種甲狀腺和甲狀旁腺疾病。 　　 3.各種乳腺疾病（乳腺癌）。 　　科室首先引進(jìn)和改進(jìn)、并在國(guó)內(nèi)率先開展深靜脈瓣膜外修復(fù)成形術(shù)治療下肢深靜脈瓣膜功能不全和開展腔鏡筋膜下交通靜脈結(jié)扎術(shù)治療下肢靜脈性潰瘍，經(jīng)近200例臨床應(yīng)用，療效良好。例數(shù)與療效居國(guó)內(nèi)領(lǐng)先地位。將下肢淺靜脈曲張手術(shù)、深靜脈瓣膜手術(shù)與腔鏡交通靜脈結(jié)扎手術(shù)有機(jī)地結(jié)合起來(lái)，建立了下肢靜脈返流性疾病的綜合性外科治療體系，治療水平達(dá)國(guó)內(nèi)領(lǐng)先水平。主動(dòng)脈夾層的腔內(nèi)介入支架治療水平達(dá)國(guó)內(nèi)先進(jìn)水平，特別是成功進(jìn)行了升主動(dòng)脈腔內(nèi)置入膜型支架治療全主動(dòng)脈夾層，據(jù)文獻(xiàn)檢索，到目前為止，國(guó)外僅正式報(bào)道1例。此外，對(duì)于腹主動(dòng)脈瘤、下肢動(dòng)脈硬化閉塞癥、頸動(dòng)脈體后等血管疾病和甲狀腺癌以及乳腺癌的外科治療或綜合性治療，都具有豐富的臨床經(jīng)驗(yàn)和較高的水平。甲狀旁腺移植治療繼發(fā)性甲狀旁腺功能低下癥的基礎(chǔ)和臨床研究水平居國(guó)內(nèi)領(lǐng)先地位，臨床治療水平達(dá)世界先進(jìn)水平。近5年來(lái)在國(guó)內(nèi)核心期刊上發(fā)表論文近80篇，參加編寫專著10部，現(xiàn)正主編"甲狀腺外科"專著，陳國(guó)銳、王深明教授主編，由人民衛(wèi)生出版社2002年出版?，F(xiàn)正擔(dān)負(fù)國(guó)家自然科學(xué)基金課題4項(xiàng)，省部級(jí)科研課題8項(xiàng)。2000年，《甲狀腺癌臨床診斷和治療的系列研究》獲得廣東省醫(yī)藥衛(wèi)生科學(xué)技術(shù)進(jìn)步三等獎(jiǎng)和2001年廣東省科技進(jìn)步三等獎(jiǎng)。 Introduce of the department of vacular and thyroid surgery The department of vacular and thyroid surgery was set up on the basis of general surgery in 1972 in our hospital, which is one of the earliest hospitals to establishing this specialized unit in the whole country .There are recently four professors(three of which are PhD supervisor),seven associate professors, one associate chief technician, three lecturers and senior physicians, one resident, one technician and fourteen specialized nurses. Our specialized academic level has been advanced in the country, and our department is the emphasized subject of the nation. The vice director of endocrinomammary surgery group, the commissioner of the vascular surgery group under China Medical Association, the vice director of breast cancer committee in Guangdong under China Anti-Tumor Association and the chief director of Guangdong vascular surgery group are also in our unit. Every year we treat more than 1200 hospitalized patients and accomplish over 1000 cases of surgeries. The diseases we mainly treat include: 1.Vascular diseases including aneurysm of thoracic and abdominal aorta,tumor of carotid body, atherosclerotic occlusion(including abdominal aorta, iliac artery, carotid and limb arteries), acute occlusion of artery, aorto-arteritis, primary deep vein insufficiency, varix of lower limb,thrombsis of deep vein, Budd-Chiara Syndrome, congenital arteriovenous malformation, thromboangiitis obliterans, injury of periperal and abdominal vessel, etc. 2. Thyroid and parathyroid diseases. 3. Breast diseases including breast carcer. It is also the first one in our country to carry out the external valvuloplasty of deep venous valve insufficiency in treating primary deep vein insufficiency and endoscopic perforator surgery(SEPS) in venous ulcer of lower limbs. By far 200 cases have been applied, the curative effects are good. The quantity and effect of cases are advanced in the country .We have set up a comprehensive surgical therapeutic system of lower limb's refluxing diseases, which is combined with the operation of varicose superficial veins ,valvuloplasty and SEPS in lower limb. The therapeutic level is preceding in the country .The interventional stent therapy of aorta dissecting aneurysm is also advanced. Particular we have successfully cure a case with dissecting aneurysm of total aorta by placing a membranous stent in the cavity of his ascending aorta, which has been formally reported only once in the world according to bibliographic retrieval. In addition, we have accumulated abundant experience on the surgical and comprehensive therapy of thyroid carcinoma, breast carcer and vascular diseases such as arteriosclerosis obliterans,internal carotid artery body tumer and abdominal aneurysm.The basic and clinic study of second hypoparathyroid therapy by transplantation is preceding in our country, and its therapeutic level is also advanced in the world. During the last five years, we have published about 80 articles on native core journals and participated in the edition of ten specialized books. Now we are editing in chief with the specialized book-Thyroid Surgery, whose chief editors are Professor Chen Guorui and Wang Shengming.It will be published by The People's Medical Publishing House in 2002.We also should the task of four subjects imbursed by National Science Fund and eight subjects imbursed by Medical Department and Guangdong Province Medical Office. The Series study of clinical dignosis and treamnent of thyroid cancer was obtained the third award of Scientific and Technological Reward for Medicine and Drug Health from Guangdong Province in 2000 and the third award of Scientific and Technological Reward for Guangdong